3/2024 Medicalgorithmics US Holding will receive $0.66 million from React Group as a sale price adjustment for Medi-Lynx

Current Report No 3/2024 Date of preparation: 01.02.2024 Legal basis: Art. 17 para. 1 of MAR Regulation – confidential information The Management Board of Medicalgorithmics S.A., based in Warsaw (“the Company”), referring to the Company’s current reports no. 47/2022 and 52/2022, informs that it has received a notification from React Health Holdings, LLC (“React Health”) […]

2/2024 Dates of publication of periodic reports in 2024

Current Report No: 2/2024 Date of preparation: 26.01.2024 Legal basis: Article 56 Section 1 Point 2 of the Act on Public Offering – current andperiodical information TheManagement Board of Medicalgorithmics S.A. with its registered office inWarsaw _the “Company”_ hereby discloses the dates ofpublication of the Company’s periodic reports in 2024: 1._#160;_#160;_#160;_#160;_#160;Annualreport and consolidated annual report […]

1/2024 Information on registration of amendment to the Company’s Articles ofAssociation

Current Report No: 1/2024 Date of preparation: 09.01.2024 Legal basis: Article 56 par. 1 point 2 of the Act on Public Offering – current andperiodic information The ManagementBoard of Medicalgorithmics S.A. with its registered office in Warsaw_the _quot;Company_quot;_ informs that today the Company received adecision dated January 8, 2024 from the District Court for the […]

36/2023 List of Shareholders Holding at Least 5% of Votes in the Total Number of Votes at the Extraordinary General Meeting of Medicalgorithmics S.A. on December 19, 2023

Current Report No: 36/2023 Date: 19.12.2023 The Management Board of Medicalgorithmics S.A., based in Warsaw (“the Company”), hereby informs that the shareholders present at the Extraordinary General Meeting of the Company convened on December 19, 2023 (“General Meeting”), held 6,219,342 (six million two hundred nineteen thousand three hundred forty-two) shares and votes, constituting 62.49% (sixty-two […]

34/2023 Adoption of final fair values for settlement of in-kind contributions in accordance with IFRS in consolidated financial statements

Current Report No: 34/2023 Date: 25.11.2023 The Management Board of Medicalgorithmics S.A., based in Warsaw (“the Company”; “Issuer”), following the information provided about the provisional recognition of the fair values of acquired assets and liabilities assumed in the contribution of Kardiolytics Inc. (“Kardiolytics”) in accordance with IFRS requirements, as published in the Issuer’s current report […]

31/2023 Notification of an Agreement between Medicalgorithmics S.A. and a Publicly Traded Global Arrhythmia Diagnosis Device Provider

Current Report No: 31/2023 Date of Preparation: October 20, 2023 Legal Basis: Art. 17 para. 1 of MAR Regulation – confidential information. The Board of Medicalgorithmics S.A. based in Warsaw (“Company”; “Issuer”) announces the signing, on October 20, 2023, of an agreement (Memorandum of Understanding, “Agreement”) with a publicly traded device manufacturer with global operations […]

30/2023 Information on Medicalgorithmics S.A. signing an agreement with a NASDAQ-listed tech company that is a leading entity in the non-invasive cardiac monitoring diagnostic sector in the US market

Subject: Information on Medicalgorithmics S.A. signing an agreement with a NASDAQ-listed tech company that is a leading entity in the non-invasive cardiac monitoring diagnostic sector in the US market Current Report No.: 30/2023 Date of preparation: 10 October 2023 Legal basis: Art. 17 para. 1 of the MAR Regulation – confidential information. The Board of […]

29/2023 Resignation of a Member of the Company’s Supervisory Board

Subject: Resignation of a Member of the Company’s Supervisory Board Current report no.: 29/2023 Date of preparation: 10 October 2023 Legal basis: Art. 56 sec. 1 point 2 of the Act on Offering – current and periodic information Management Board of Medicalgorithmics S.A. headquartered in Warsaw (“Company“) hereby informs that on October 10, 2023, Mr. […]

28/2023 Subject: Announcement on Medicalgorithmics S.A., Warsaw, Entering into a Strategic Alliance Agreement with a U.S. Distributor28/2023

Current Report No.: 28/2023 Date of Preparation: October 5, 2023 Legal Basis: Article 17(1) of the MAR Regulation – confidential information. The Board of Medicalgorithmics S.A., based in Poland, Warsaw (“Company”; “Issuer”), hereby announces that on October 5, 2023, the Company, as the Seller, has entered into a Strategic Alliance Agreement (“Agreement”, “SSA”) with a […]

Your submission was succesfull

Software

Get more information
The data administrator is Medicalgorithmics S.A. with its registered office in Warsaw (02-001) at Al. Jerozolimskie 81. The data will be processed in order to answer the query sent (legal basis: legitimate interest of the administrator), marketing (legal basis: legitimate interest of the administrator). The full text of the clause can be found on the Privacy Policy page.

VCAST

Get a free demo
The data administrator is Medicalgorithmics S.A. with its registered office in Warsaw (02-001) at Al. Jerozolimskie 81. The data will be processed in order to answer the query sent (legal basis: legitimate interest of the administrator), marketing (legal basis: legitimate interest of the administrator). The full text of the clause can be found on the Privacy Policy page.

DRAI

Get a free demo
The data administrator is Medicalgorithmics S.A. with its registered office in Warsaw (02-001) at Al. Jerozolimskie 81. The data will be processed in order to answer the query sent (legal basis: legitimate interest of the administrator), marketing (legal basis: legitimate interest of the administrator). The full text of the clause can be found on the Privacy Policy page.

Our company

About us

Our History

Management Team

Partners

Career

Work with us

Job offers

Recommend an employee

Application form